Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > Weekly NIH Funding Opportunities, Notices: May 5, 2017

Weekly NIH Funding Opportunities, Notices: May 5, 2017



Notices
Requests for Applications

     

  • Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)
    (RFA-AR-18-002)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt Date(s): August 7, 2017; December 4, 2017; April 2, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R21)
    (RFA-AR-18-003)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Application Receipt Date(s): August 7, 2017; December 4, 2017; April 2, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Cystic Fibrosis Research and Translation Center (P30)
    (RFA-DK-17-007)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Data Coordinating Center for the NICHD Neonatal Research Network (U24)
    (RFA-HD-18-010)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01)
    (RFA-MH-18-300)
    National Institute of Mental Health
    National Institute on Drug Abuse
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21)
    (RFA-MH-18-301)
    National Institute of Mental Health
    National Institute on Drug Abuse
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
Program Announcements